<DOC>
	<DOC>NCT01012999</DOC>
	<brief_summary>The purpose of this study is to determine the appropriate dose and effectiveness of intra-nasal administration of a potent narcotic, sufentanil, for the treatment of moderate to severe pain due to broken bone(s) in the arm or leg.</brief_summary>
	<brief_title>A Dosing and Efficacy Study of Intra-nasal Sufentanil for Moderate to Severe Pain</brief_title>
	<detailed_description />
	<mesh_term>Sufentanil</mesh_term>
	<criteria>18 yo or older; isolated traumatic injury to upper or lower extremity; alert and oriented to name, date, place; patient has a numeric pain score of 5 or higher; speaks English as their primary language; female patients are on birth control, menopausal, or are sterile (hysterectomy, tubal ligation) injury isolated to a finger or toe; previous nasal or sinus surgery; chronic nasal problem; acute nasal problem (ie epistaxis, URI, sinusitis); pregnant; prisoner; allergy to sufentanil, fentanyl, or alfentanil; history of analgesic abuse or dependency; presence of other painful injuries; systolic BP less than 100 mm Hg; patient seems or is confused or has a head injury; room air oxygenation less than 95%; patient has COPD, severe asthma, oxygendependent pulmonary disease; impaired hepatic or renal function (obtained clinically or by history); weight more than 230 lbs (100 kg); alcohol or drug intoxication (per patient admission or clinical assessment of physician); elderly (&gt; 70 years)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>acute pain, intranasal, sufentanil,</keyword>
	<keyword>Acute pain control with an intranasal opiate</keyword>
</DOC>